AST 0 3 0 3 B-clinical_variable
( 4 5 4 5 O
SGOT 5 9 5 9 B-clinical_variable
) 9 10 9 10 O
& 11 12 11 12 O
ALT 13 16 13 16 B-clinical_variable
( 17 18 17 18 O
SGPT 18 22 18 22 B-clinical_variable
) 22 23 22 23 O
≤ 24 25 24 25 O
2.5 26 29 26 29 B-upper_bound
x 30 31 30 31 I-upper_bound
ULN 32 35 32 35 I-upper_bound
( 36 37 36 37 O
for 37 40 37 40 O
patients 41 49 41 49 O
with 50 54 50 54 O
liver 55 60 55 60 B-cancer
metastases 61 71 61 71 I-cancer
, 71 72 71 72 O
AST&ALT 73 80 73 80 O
< 81 82 81 82 O
5xULN 83 88 83 88 B-upper_bound
) 88 89 88 89 O

Age 0 3 90 93 B-age
≥ 4 5 94 95 O
18 6 8 96 98 B-lower_bound

Alkaline 0 8 99 107 B-clinical_variable
phosphatase 9 20 108 119 I-clinical_variable
< 21 22 120 121 O
2.5xULN 23 30 122 129 B-upper_bound
, 30 31 129 130 O
unless 32 38 131 137 O
bone 39 43 138 142 B-cancer
metastasis 44 54 143 153 I-cancer
is 55 57 154 156 O
present 58 65 157 164 O
and 66 69 165 168 O
in 70 72 169 171 O
the 73 76 172 175 O
absence 77 84 176 183 O
of 85 87 184 186 O
liver 88 93 187 192 B-cancer
metastasis 94 104 193 203 I-cancer

Creatinine 0 10 204 214 B-clinical_variable
≤ 11 12 215 216 O
1.5 13 16 217 220 B-upper_bound
mg 17 19 221 223 I-upper_bound
/ 19 20 223 224 I-upper_bound
dL 20 22 224 226 I-upper_bound
-or- 23 27 227 231 O
creatinine 28 38 232 242 B-clinical_variable
clearance 39 48 243 252 I-clinical_variable
≥ 49 50 253 254 O
60 51 53 255 257 B-lower_bound
mL 54 56 258 260 I-lower_bound
/ 56 57 260 261 I-lower_bound
min 57 60 261 264 I-lower_bound

ECOG 0 4 265 269 B-clinical_variable
performance 5 16 270 281 I-clinical_variable
status 17 23 282 288 I-clinical_variable
0 24 25 289 290 B-lower_bound
or 26 28 291 293 O
1 29 30 294 295 B-upper_bound

Laparoscopy 0 11 296 307 B-treatment
and 12 15 308 311 O
central 16 23 312 319 B-treatment
venous 24 30 320 326 I-treatment
catheter 31 39 327 335 I-treatment
placement 40 49 336 345 I-treatment

Metastatic 0 10 346 356 B-cancer
advanced 11 19 357 365 O
disease 20 27 366 373 O

Neutrophils 0 11 374 385 B-clinical_variable
≥ 12 13 386 387 O
1,500 14 19 388 393 B-lower_bound
/ 19 20 393 394 I-lower_bound
mm3 20 23 394 397 I-lower_bound

No 0 2 398 400 O
major 3 8 401 406 B-treatment
surgery 9 16 407 414 I-treatment
within 17 23 415 421 O
3 24 25 422 423 B-upper_bound
weeks 26 31 424 429 I-upper_bound
of 32 34 430 432 O
the 35 38 433 436 O
start 39 44 437 442 O
of 45 47 443 445 O
study 48 53 446 451 O
treatment 54 63 452 461 B-treatment

No 0 2 462 464 O
prior 3 8 465 470 B-treatment
chemotherapy 9 21 471 483 I-treatment
for 22 25 484 487 O
pancreatic 26 36 488 498 B-cancer
cancer 37 43 499 505 I-cancer

No 0 2 506 508 O
prior 3 8 509 514 O
invasive 9 17 515 523 B-cancer
malignancy 18 28 524 534 I-cancer
within 29 35 535 541 O
the 36 39 542 545 O
prior 40 45 546 551 B-upper_bound
two 46 49 552 555 I-upper_bound
years 50 55 556 561 I-upper_bound

Not 0 3 562 565 B-pregnancy
pregnant 4 12 566 574 I-pregnancy

Pathologically 0 14 575 589 O
or 15 17 590 592 O
cytological 18 29 593 604 O
confirmed 30 39 605 614 O
pancreatic 40 50 615 625 B-cancer
ductal 51 57 626 632 I-cancer
adenocarcinoma 58 72 633 647 I-cancer

Patients 0 8 648 656 O
must 9 13 657 661 O
have 14 18 662 666 O
recovered 19 28 667 676 O
from 29 33 677 681 O
the 34 37 682 685 O
side 38 42 686 690 O
effects 43 50 691 698 O
of 51 53 699 701 O
any 54 57 702 705 O
major 58 63 706 711 B-treatment
surgery 64 71 712 719 I-treatment
at 72 74 720 722 O
the 75 78 723 726 O
start 79 84 727 732 O
of 85 87 733 735 O
study 88 93 736 741 O
treatment 94 103 742 751 B-treatment

Patients 0 8 752 760 O
with 9 13 761 765 O
a 14 15 766 767 O
history 16 23 768 775 O
of 24 26 776 778 O
interstitial 27 39 779 791 B-chronic_disease
lung 40 44 792 796 I-chronic_disease
disease 45 52 797 804 I-chronic_disease

Patients 0 8 805 813 O
with 9 13 814 818 O
known 14 19 819 824 O
brain 20 25 825 830 B-cancer
metastases 26 36 831 841 I-cancer

Patients 0 8 842 850 O
with 9 13 851 855 O
pathology 14 23 856 865 O
or 24 26 866 868 O
cytology 27 35 869 877 O
showing 36 43 878 885 O
carcinoma 44 53 886 895 B-cancer
of 54 56 896 898 I-cancer
pancreas 57 65 899 907 I-cancer
or 66 68 908 910 O
adenosquamous 69 82 911 924 B-cancer
of 83 85 925 927 I-cancer
the 86 89 928 931 I-cancer
pancreas 90 98 932 940 I-cancer

Patients 0 8 941 949 O
with 9 13 950 954 O
sepsis 14 20 955 961 B-chronic_disease
or 21 23 962 964 O
pneumonitis 24 35 965 976 B-chronic_disease

Patients 0 8 977 985 O
with 9 13 986 990 O
serious 14 21 991 998 O
medical 22 29 999 1006 O
risk 30 34 1007 1011 O
factors 35 42 1012 1019 O
involving 43 52 1020 1029 O
any 53 56 1030 1033 O
of 57 59 1034 1036 O
the 60 63 1037 1040 O
major 64 69 1041 1046 O
organ 70 75 1047 1052 O
systems 76 83 1053 1060 O
such 84 88 1061 1065 O
that 89 93 1066 1070 O
the 94 97 1071 1074 O
investigator 98 110 1075 1087 O
considers 111 120 1088 1097 O
it 121 123 1098 1100 O
unsafe 124 130 1101 1107 O
for 131 134 1108 1111 O
the 135 138 1112 1115 O
patient 139 146 1116 1123 O
to 147 149 1124 1126 O
receive 150 157 1127 1134 O
FOLFOX 158 164 1135 1141 B-treatment
- 164 165 1141 1142 I-treatment
A 165 166 1142 1143 I-treatment

Patients 0 8 1144 1152 O
with 9 13 1153 1157 O
unstable 14 22 1158 1166 O
biliary 23 30 1167 1174 B-treatment
stents 31 37 1175 1181 I-treatment
or 38 40 1182 1184 O
with 41 45 1185 1189 O
plastic 46 53 1190 1197 B-treatment
stents 54 60 1198 1204 I-treatment
. 60 61 1204 1205 O
Information 62 73 1206 1217 O
on 74 76 1218 1220 O
type 77 81 1221 1225 O
of 82 84 1226 1228 O
stent 85 90 1229 1234 O
is 91 93 1235 1237 O
required 94 102 1238 1246 O
at 103 105 1247 1249 O
registration 106 118 1250 1262 O

Platelet 0 8 1263 1271 B-clinical_variable
count 9 14 1272 1277 I-clinical_variable
≥ 15 16 1278 1279 O
100,000 17 24 1280 1287 B-lower_bound
/ 24 25 1287 1288 I-lower_bound
mm3 25 28 1288 1291 I-lower_bound

Post 0 4 1292 1296 O
- 4 5 1296 1297 O
menopausal 5 15 1297 1307 O
women 16 21 1308 1313 B-gender

Preexisting 0 11 1314 1325 O
neuropathy 12 22 1326 1336 B-chronic_disease

Prior 0 5 1337 1342 O
hypersensitivity 6 22 1343 1359 O
to 23 25 1360 1362 O
Oxaliplatin 26 37 1363 1374 B-allergy_name
or 38 40 1375 1377 O
Abraxane 41 49 1378 1386 B-allergy_name
® 50 51 1387 1388 I-allergy_name
that 52 56 1389 1393 O
in 57 59 1394 1396 O
the 60 63 1397 1400 O
investigators 64 77 1401 1414 O
opinion 78 85 1415 1422 O
would 86 91 1423 1428 O
put 92 95 1429 1432 O
the 96 99 1433 1436 O
patient 100 107 1437 1444 O
at 108 110 1445 1447 O
risk 111 115 1448 1452 O
if 116 118 1453 1455 O
re 119 121 1456 1458 O
- 121 122 1458 1459 O
exposed 122 129 1459 1466 O

Total 0 5 1467 1472 B-clinical_variable
bilirubin 6 15 1473 1482 I-clinical_variable
≤ 16 17 1483 1484 O
1.25 18 22 1485 1489 B-upper_bound
x 23 24 1490 1491 I-upper_bound
ULN 25 28 1492 1495 I-upper_bound

Uncontrolled 0 12 1496 1508 B-chronic_disease
diabetes 13 21 1509 1517 I-chronic_disease

Women 0 5 1518 1523 B-gender
of 6 8 1524 1526 O
child 9 14 1527 1532 O
bearing 15 22 1533 1540 O
potential 23 32 1541 1550 O
must 33 37 1551 1555 O
have 38 42 1556 1560 O
a 43 44 1561 1562 O
negative 45 53 1563 1571 B-pregnancy
serum 54 59 1572 1577 I-pregnancy
or 60 62 1578 1580 I-pregnancy
urine 63 68 1581 1586 I-pregnancy
pregnancy 69 78 1587 1596 I-pregnancy
test 79 83 1597 1601 O
( 84 85 1602 1603 O
minimum 85 92 1603 1610 O
sensitivity 93 104 1611 1622 O
25 105 107 1623 1625 B-lower_bound
IU 108 110 1626 1628 I-lower_bound
/ 110 111 1628 1629 I-lower_bound
L 111 112 1629 1630 I-lower_bound
or 113 115 1631 1633 O
equivalent 116 126 1634 1644 O
units 127 132 1645 1650 O
of 133 135 1651 1653 O
HCG 136 139 1654 1657 B-clinical_variable
) 139 140 1657 1658 O
within 141 147 1659 1665 O
7 148 149 1666 1667 B-upper_bound
days 150 154 1668 1672 I-upper_bound
prior 155 160 1673 1678 I-upper_bound
to 161 163 1679 1681 O
beginning 164 173 1682 1691 O
of 174 176 1692 1694 O
treatment 177 186 1695 1704 B-treatment

history 0 7 1705 1712 O
of 8 10 1713 1715 O
slowly 11 17 1716 1722 O
progressive 18 29 1723 1734 O
dyspnea 30 37 1735 1742 B-chronic_disease
and 38 41 1743 1746 O
unproductive 42 54 1747 1759 O
cough 55 60 1760 1765 B-chronic_disease
, 60 61 1765 1766 O
sarcoidosis 62 73 1767 1778 B-chronic_disease
, 73 74 1778 1779 O
silicosis 75 84 1780 1789 B-chronic_disease
, 84 85 1789 1790 O
idiopathic 86 96 1791 1801 B-chronic_disease
pulmonary 97 106 1802 1811 I-chronic_disease
fibrosis 107 115 1812 1820 I-chronic_disease
, 115 116 1820 1821 O
pulmonary 117 126 1822 1831 O
hypersensitivity 127 143 1832 1848 B-chronic_disease
pneumonitis 144 155 1849 1860 I-chronic_disease

known 0 5 1861 1866 O
historical 6 16 1867 1877 O
or 17 19 1878 1880 O
active 20 26 1881 1887 B-chronic_disease
infection 27 36 1888 1897 I-chronic_disease
with 37 41 1898 1902 O
HIV 42 45 1903 1906 B-chronic_disease
, 45 46 1906 1907 O
hepatitis 47 56 1908 1917 B-chronic_disease
B 57 58 1918 1919 I-chronic_disease
, 58 59 1919 1920 O
or 60 62 1921 1923 O
hepatitis 63 72 1924 1933 B-chronic_disease
C 73 74 1934 1935 I-chronic_disease

multiple 0 8 1936 1944 O
allergies 9 18 1945 1954 B-allergy_name
that 19 23 1955 1959 O
in 24 26 1960 1962 O
the 27 30 1963 1966 O
investigator 31 43 1967 1979 O
's 43 45 1979 1981 O
opinion 46 53 1982 1989 O
would 54 59 1990 1995 O
put 60 63 1996 1999 O
the 64 67 2000 2003 O
patient 68 75 2004 2011 O
at 76 78 2012 2014 O
an 79 81 2015 2017 O
increased 82 91 2018 2027 O
risk 92 96 2028 2032 O

patients 0 8 2033 2041 O
on 9 11 2042 2044 O
antibiotics 12 23 2045 2056 B-treatment
for 24 27 2057 2060 O
infection 28 37 2061 2070 O
or 38 40 2071 2073 O
patients 41 49 2074 2082 O
getting 50 57 2083 2090 O
over 58 62 2091 2095 O
a 63 64 2096 2097 O
cold 65 69 2098 2102 B-chronic_disease
or 70 72 2103 2105 O
seasonal 73 81 2106 2114 B-chronic_disease
virus 82 87 2115 2120 I-chronic_disease

patients 0 8 2121 2129 O
with 9 13 2130 2134 O
an 14 16 2135 2137 O
early 17 22 2138 2143 O
stage 23 28 2144 2149 O
malignancy 29 39 2150 2160 B-cancer
that 40 44 2161 2165 O
is 45 47 2166 2168 O
not 48 51 2169 2172 O
expected 52 60 2173 2181 O
to 61 63 2182 2184 O
require 64 71 2185 2192 O
treatment 72 81 2193 2202 B-treatment
in 82 84 2203 2205 O
the 85 88 2206 2209 O
next 89 93 2210 2214 B-upper_bound
2 94 95 2215 2216 I-upper_bound
years 96 101 2217 2222 I-upper_bound
( 102 103 2223 2224 O
such 103 107 2224 2228 O
as 108 110 2229 2231 O
early 111 116 2232 2237 O
stage 117 122 2238 2243 O
, 122 123 2243 2244 O
resected 124 132 2245 2253 O
breast 133 139 2254 2260 B-cancer
cancer 140 146 2261 2267 I-cancer
or 147 149 2268 2270 O
asymptomatic 150 162 2271 2283 O
prostate 163 171 2284 2292 B-cancer
cancer 172 178 2293 2299 I-cancer
) 178 179 2299 2300 O

surgical 0 8 2301 2309 O
menopause 9 18 2310 2319 O
or 19 21 2320 2322 O
lack 22 26 2323 2327 O
of 27 29 2328 2330 O
menses 30 36 2331 2337 O
> 37 38 2338 2339 O
12 38 40 2339 2341 B-lower_bound
months 41 47 2342 2348 I-lower_bound

